Follow the latest updates
Sir Ganga Ram Hospital has reported five cases of Cytomegalovirus-related rectal bleeding in patients who had earlier tested positive for Covid-19. One of them died due to “massive bleeding and severe Covid chest disease,” the hospital said.
Dr Anil Arora from the hospital was quoted as saying in media reports that the patients presented with symptoms like abdominal pain and bleeding in stools an average of 20 至 30 days after their first Covid diagnosis.
He said that Cytomegalovirus exists in the body in an asymptomatic form, but symptoms are seen when a person’s immunity is compromised, according to news agency PTI. Covid-19 and the medicines used in its treatment affect immunity, making a person more susceptible to other infections, 他说.
同时, the developers of Russia’s Sputnik V vaccine have said that the shot is 90 per cent effective against the Delta variant of Covid-19, which was first detected in India.
Indian vaccine effective against Delta variant, says US health institute
The US’ National Institute of Health has said that India’s homegrown Covid-19 vaccine ‘Covaxin’ — made by Bharat Biotech — effectively neutralises both Alpha and Delta variants of coronavirus.
Alpha variant was first identified in the UK and Delta was detected in India.
Bharat Biotech last week had a pre-submission meeting with the World Health Organisation for emergency use listing of Covaxin.
Indian minister takes up Covishield authorisation with EU
India’s external affairs minister S Jaishankar said he has raised the matter of authorisation of Covishield — the Oxford-AstraZeneca shot made by Serum Institute of India — for travel to the EU.
He discussed it during a meeting with Josep Borell Fontelles, high representative of the EU for foreign affairs and security policy, on the sidelines of the G20 ministerial meetings.
This comes amid reports that Indians inoculated with Covishield may not be eligible for EU’s green pass because it’s not one of the vaccines approved by the European Medicines Agency.
然而, ambassador of the European Union to India and Bhutan Ugo Astuto has said that green pass is not a precondition to travel and states can choose to accept vaccines approve by the World Health Organisation.
Brazil to suspend deal to buy Indian vaccine
Brazil will temporarily suspend a deal to buy India’s indigenous Covid-19 vaccine Covaxin — made by Bharat Biotech — after allegations of irregularities in the contract.
Brazil’s health ministry said in a statement that the preliminary analysis of federal comptroller CGU found no irregularities, but the suspension decision follows compliance practices and won’t affect the vaccination drive in the country.
Brazilian federal prosecutors are investigating the deal. President Jair Bolsonaro has denied being aware of any irregularities.
India says 49% people over 60 vaccinated with first dose
The Indian government has said that 49 per cent of its population over the age of 60 years has been vaccinated with at least one dose of Covid-19 vaccine.
The country launched its vaccination drive on 16 January and has only fully inoculated about 5 per cent of its population so far. It began vaccinating people aged 60 or above from 1 行进.
India is looking to ramp up its vaccination drive to reach its goal of inoculating the entire adult population by the end of December.
Good morning, 欢迎来到 独立报 coverage of the coronavirus pandemic for Wednesday 30 六月, 2021.